Skip to main content

Together we are beating cancer

Donate now

Vaccination

Showing 12 out of 50 results
vaccine vials on a production line with a gloved hand reaching to grab one of them

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

by Sophie Wedekind | News | 4 October 2024

4 October 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024

A young Nepalese girl standing among a group of women

Through the International Cancer Prevention programme, we’re helping to expand access to HPV vaccination for adolescent girls in low and middle income countries, to prevent cervical cancer. Through the International Cancer Prevention programme, we’re helping to expand access to HPV vaccination for adolescent girls in low and middle income countries, to prevent cervical cancer.

by Elle Pearson | News | 24 June 2024

24 June 2024

Squamous epithelial cells of human cervix under the microscope view.
  • Science & Technology
  • Health & Medicine

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 17 June 2024

17 June 2024

An unrecognisable young girl receiving a vaccination.

The HPV vaccine is preventing the highest number of cervical cancer cases in the most deprived groups in England. The HPV vaccine is preventing the highest number of cervical cancer cases in the most deprived groups in England.

by Tim Gunn | News | 16 May 2024

16 May 2024

Vaccine vial and needle

Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, reflects on today's news that Moderna and MSD’s melanoma cancer vaccine is moving to Phase 3 clinical trials

by Iain Foulkes | Opinion | 26 April 2024

26 April 2024

Vaccine vial bottles

Researchers have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine Researchers have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine

by Sophie Wedekind | News | 22 March 2024

22 March 2024

Stained cervical cells viewed under the microscope

22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer. 22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer.

by Jacob Smith | Analysis | 22 January 2024

22 January 2024

Vaccine vial and needle

Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023. Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023.

by In collaboration with PA Media Group | News | 21 June 2023

21 June 2023

CRUK and UICC’s Tobacco Control Partnership in Kenya and Uganda is launched at the World Cancer Congress
  • Health & Medicine
  • Policy & Insight

Reflections from the World Cancer Congress

Across the diverse audience of cancer researchers, health policy professionals, government officials and cancer survivors there was a common desire at the World Cancer Congress: to make up for lost time.  Across the diverse audience of cancer researchers, health policy professionals, government officials and cancer survivors there was a common desire at the World Cancer Congress: to make up for lost time. 

by George Hayes | Analysis | 30 November 2022

30 November 2022

This entry is part 3 of 3 in the series CRUK Global
A bottle containing the HPV vaccine

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

by Lilly Matson | In depth | 21 November 2022

21 November 2022